Samples; Testing; Release. Within seven (7) days after Catalent’s completion of Processing of each Batch, Catalent shall provide Client or its designee with Catalent’s Certificate of Analysis for such Batch certifying that the Product conforms to the Specifications. Catalent will make available to Client copies of all documentation and test results that are reasonably necessary to demonstrate conformity to the Specifications for the first five (5) post-validation commercial Batches. Client shall be solely responsible for final release of the Product, at its cost. No later than thirty (30) days after Product delivery (“Review Period”), Client or its designee shall notify Catalent of any rejection of the Product. Client’s failure to reject Product for non-conformity to Specifications during the Review Period shall constitute acceptance of the Product.
Appears in 3 contracts
Samples: Softgel Commercial Manufacturing Agreement (Blue Water Acquisition Corp.), Softgel Commercial Manufacturing Agreement (Clarus Therapeutics Inc), Softgel Commercial Manufacturing Agreement (Clarus Therapeutics Inc)
Samples; Testing; Release. Within seven (7) days after Catalent’s 's completion of Processing of each Batch, Catalent shall provide Client or its designee with Catalent’s 's Certificate of Analysis for such Batch certifying that the Product conforms to the Specifications. Catalent will make available to Client copies of all documentation and test results that are reasonably necessary to demonstrate conformity to the Specifications for the first five (5) post-validation commercial Batches. Client shall be solely responsible for final release of the Product, at its cost. No later than thirty (30) days after Product delivery (“"Review Period”"), Client or its designee shall notify Catalent of any rejection of the Product. Client’s 's failure to reject Product for non-conformity to Specifications during the Review Period shall constitute acceptance of the Product.
Appears in 1 contract
Samples: Softgel Commercial Manufacturing Agreement (Clarus Therapeutics Inc)